<DOC>
	<DOCNO>NCT01734798</DOCNO>
	<brief_summary>Radical Cystectomy still standard treatment muscle-invasive Bladder cancer . Local recurrence still major cause failure together distant metastasis . postoperative radiotherapy succeed decrease local recurrence hence improve overall survival . Adjuvant chemotherapy also improve survival different study . This study perform test efficacy toxicity add two modality together compare modality alone .</brief_summary>
	<brief_title>Adjuvant Post-radical Cystectomy Treatment Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients 70 year old . Radical cystectomy perform within 42 day microscopic macroscopic residual surgery ( negative surgical safety margin ) Having one risk factor ( P3b , P4a , G3 /or positive LN ) ECOG Performance Scale ( 02 ) . Adequate liver function . Adequate renal function serum ( creatinine &lt; 1.5 mg ) . No evidence distant metastasis malignancy . patient receive radiotherapy chemotherapy prior radical cystectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>locally advanced bladder cancer</keyword>
	<keyword>Postoperative radiotherapy</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
	<keyword>Radical Cystectomy</keyword>
</DOC>